提高癌症患者接种疫苗的质量改善干预措施:系统性审查
概括
质量改善干预措施显著提高了癌症患者的疫苗接种率,解决了预防感染的关键差距. 这些策略提高了患者的知识,并简化了获得流感和肺炎球菌疫苗等关键疫苗的机会.
科学领域:
- 在瘤学瘤学.
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 癌症患者的免疫系统已经减弱,增加了他们对感染的易感性.
- 在这一群体中,低于最佳的疫苗接种率有助于可预防的发病率和死亡率.
- 关于改善癌症患者接种疫苗的有效干预措施的研究有限.
研究的目的:
- 系统地审查旨在增加癌症患者接种疫苗的质量改善 (QI) 干预措施.
- 确定使用的QI干预类型及其有效性.
主要方法:
- 在PubMed和Cochrane图书馆进行了全面的文献搜索.
- 研究被独立选,数据由两位作者提取.
- 2014年至2022年间发表的13项研究符合纳入标准.
主要成果:
- 干预的重点是流感和肺炎球菌疫苗.
- 大多数研究采用多种QI策略,包括增强患者/家庭知识和预约前识别符合条件的患者.
- 所有包括的研究报告说,干预实施后疫苗接种率有所改善.
结论:
- 质量改善干预措施在增加癌症患者接种流感和肺炎球菌疫苗方面是有效的.
- 未来的研究应该调查实施这些干预措施的障碍.
- 需要进一步的研究来评估这些干预措施对其他疫苗类型的影响.
相关概念视频
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Vaccinations
44.5K
Overview
44.5K
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
2.2K
Creating and executing a nursing diagnosis helps nurses plan care and guide patient, family, and community interventions. They are developed based on a patient's physical evaluation and support measuring the outcomes. It is not recommended to select random interventions throughout the planning process. Instead, consider the following six essential factors when choosing interventions:
2.2K


